Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shashen Maidong granules for subacute and chronic cough
CTR20171632Phase 2Completed
- Sponsor
- Hubei Liyi Pharmaceutical Technology
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shashen maidong granules in Subacute cough, chronic cough, cough variant asthma (CVA), sponsored by Hubei Liyi Pharmaceutical Technology. Started Jan 2018; status: completed.
02
Drugs
shashen maidong granules
03
Conditions
Subacute coughchronic coughcough variant asthma (CVA)
Beyond the preview
Go deeper on CTR20171632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171632.